Berbamine (BBM), a Natural STAT3 Inhibitor, Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells

[Image: see text] Sorafenib (SORA), a multi kinase inhibitor, is the standard first-line targeted therapy approved by the Food and Drug Administration for advanced hepatocellular carcinoma (HCC). However, emerging evidence from clinical practice indicates that SORA alone has only moderate antitumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Weijia, Bai, Binglong, Hong, Zhong, Zhang, Xuming, Zhou, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528295/
https://www.ncbi.nlm.nih.gov/pubmed/33015502
http://dx.doi.org/10.1021/acsomega.0c03527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528295/
https://www.ncbi.nlm.nih.gov/pubmed/33015502
http://dx.doi.org/10.1021/acsomega.0c03527

Ejemplares similares